Physician profile
Jay H Kim
NPI 1922000447
$8,322.52
in general payments reported to CMS, 2019-2025
46 companies · $2,536 in 2025
The $2,536 reported for 2025 was more than what 84% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $855 · 2020: $587 · 2021: $720 · 2022: $1,136 · 2023: $1,324 · 2024: $1,164 · 2025: $2,536.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,847 · Travel and Lodging: $677 · Honoraria: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,847.34 |
| Travel and Lodging | $677.08 |
| Honoraria | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,300.40 | 2024-2025 | Aquabeam System |
| Janssen Biotech, INC. | $877.60 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $669.73 | 2019-2023 | Myrbetriq |
| Verity Pharmaceuticals INC. | $645.81 | 2021-2025 | Trelstar, Tlando |
| Myriad Genetic Laboratories, INC. | $616.46 | 2021-2025 | Prolaris |
| Telix Pharmaceuticals | $476.99 | 2022-2025 | Illuccix |
| Amniox Medical, INC. | $374.05 | 2019-2020 | |
| Endo Pharmaceuticals INC. | $305.01 | 2019-2022 | |
| Axonics, INC. | $285.31 | 2022-2024 | Axonics |
| Antares Pharma, INC. | $266.86 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Olympus America INC. | $254.14 | 2024-2025 | Gyrus Acmi, Soltive, Olympus |
| Pfizer INC. | $182.79 | 2019-2022 | |
| Endo USA, INC. | $182.46 | 2024-2025 | Xiaflex |
| Coloplast Corp | $178.21 | 2019-2023 | Porges Coloplast, Titan |
| Abbvie INC. | $176.34 | 2021-2025 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.